Pediatrix Medical Group, Inc. (NYSE:MD) Given Average Recommendation of “Hold” by Brokerages

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have been assigned an average recommendation of “Hold” from the six research firms that are covering the stock, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $16.25.

A number of equities research analysts recently commented on the company. Jefferies Financial Group upped their target price on Pediatrix Medical Group from $14.00 to $18.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. StockNews.com raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Truist Financial lowered their price target on shares of Pediatrix Medical Group from $16.00 to $15.00 and set a “hold” rating on the stock in a report on Monday, January 6th. Finally, UBS Group lifted their price objective on Pediatrix Medical Group from $10.50 to $16.50 and gave the company a “neutral” rating in a research note on Tuesday, November 5th.

Insiders Place Their Bets

In other Pediatrix Medical Group news, Director Mark S. Ordan sold 27,600 shares of the firm’s stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $15.35, for a total transaction of $423,660.00. Following the completion of the sale, the director now owns 138,683 shares of the company’s stock, valued at $2,128,784.05. This trade represents a 16.60 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Mary Ann E. Moore sold 8,108 shares of the company’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $16.00, for a total value of $129,728.00. Following the completion of the transaction, the executive vice president now directly owns 135,810 shares in the company, valued at approximately $2,172,960. This trade represents a 5.63 % decrease in their position. The disclosure for this sale can be found here. 2.00% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Pediatrix Medical Group

Large investors have recently made changes to their positions in the stock. American Century Companies Inc. lifted its stake in Pediatrix Medical Group by 13.7% during the 2nd quarter. American Century Companies Inc. now owns 124,395 shares of the company’s stock worth $939,000 after acquiring an additional 15,023 shares in the last quarter. Vanguard Personalized Indexing Management LLC purchased a new stake in Pediatrix Medical Group during the second quarter worth about $81,000. Hsbc Holdings PLC lifted its position in shares of Pediatrix Medical Group by 29.3% during the second quarter. Hsbc Holdings PLC now owns 30,502 shares of the company’s stock worth $227,000 after purchasing an additional 6,921 shares in the last quarter. Intech Investment Management LLC purchased a new position in shares of Pediatrix Medical Group in the second quarter valued at approximately $237,000. Finally, Canada Pension Plan Investment Board acquired a new position in shares of Pediatrix Medical Group in the second quarter valued at approximately $72,000. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Stock Performance

Shares of MD stock opened at $14.30 on Friday. Pediatrix Medical Group has a 12-month low of $6.62 and a 12-month high of $16.41. The business’s fifty day simple moving average is $14.00 and its 200-day simple moving average is $12.03. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 0.83. The company has a market cap of $1.23 billion, a PE ratio of -4.67, a PEG ratio of 1.42 and a beta of 1.58.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings results on Friday, November 1st. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.07. Pediatrix Medical Group had a positive return on equity of 12.79% and a negative net margin of 12.65%. The business had revenue of $511.20 million during the quarter, compared to the consensus estimate of $498.87 million. During the same quarter last year, the company earned $0.29 earnings per share. The company’s quarterly revenue was up .9% on a year-over-year basis. Analysts expect that Pediatrix Medical Group will post 1.26 earnings per share for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.